Seeing Is Believing

Currently out of the existing stock ratings of Hartaj Singh, 227 are a BUY (96.6%), 8 are a HOLD (3.4%).
Analyst Hartaj Singh, carries an average stock price target met ratio of 44.98% that have a potential upside of 32.61% achieved within 306 days. Previously, Hartaj Singh worked at OPPENHEIMER, BTIG.
Hartaj Singh’s has documented 439 price targets and ratings displayed on 36 stocks. The coverage was on Healthcare, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 04-May-2026.
Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for MRNA (MODERNA) at 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%) receiving and performance score of 77.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 5 months 29 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 6 months ago
(03-May-2021)
18/29 (62.07%)
$2.73 (1.60%)
667
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 6 months 9 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 8 months 30 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 08-Feb-2018
$166
$-16.5 (-9.04%)
$179
5 years 8 months 30 days ago
(04-Feb-2021)
21/21 (100%)
$10.41 (6.69%)
711